Acura Pharmaceuticals EPS - Earnings per Share 2010-2021 | ACUR
Acura Pharmaceuticals eps - earnings per share from 2010 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Acura Pharmaceuticals Annual EPS |
| 2021 |
$-0.02 |
| 2020 |
$-0.04 |
| 2019 |
$-0.14 |
| 2018 |
$-0.18 |
| 2017 |
$-0.36 |
| 2016 |
$-0.62 |
| 2015 |
$-0.46 |
| 2014 |
$-1.35 |
| 2013 |
$-1.45 |
| 2012 |
$-1.00 |
| 2011 |
$1.10 |
| 2010 |
$-1.35 |
| 2009 |
$-1.75 |
| Acura Pharmaceuticals Quarterly EPS |
| 2021-12-31 |
$0.00 |
| 2021-09-30 |
$0.00 |
| 2021-06-30 |
$-0.01 |
| 2021-03-31 |
$-0.01 |
| 2020-12-31 |
$-0.01 |
| 2020-09-30 |
$-0.02 |
| 2020-06-30 |
$0.01 |
| 2020-03-31 |
$-0.02 |
| 2019-12-31 |
$0.05 |
| 2019-09-30 |
$0.00 |
| 2019-06-30 |
$-0.15 |
| 2019-03-31 |
$-0.04 |
| 2018-12-31 |
$0.00 |
| 2018-09-30 |
$-0.05 |
| 2018-06-30 |
$-0.06 |
| 2018-03-31 |
$-0.07 |
| 2017-12-31 |
$-0.09 |
| 2017-09-30 |
$-0.12 |
| 2017-06-30 |
$-0.18 |
| 2017-03-31 |
$0.03 |
| 2016-12-31 |
$0.13 |
| 2016-09-30 |
$-0.19 |
| 2016-06-30 |
$-0.28 |
| 2016-03-31 |
$-0.28 |
| 2015-12-31 |
$-0.09 |
| 2015-09-30 |
$-0.23 |
| 2015-06-30 |
$-0.27 |
| 2015-03-31 |
$0.13 |
| 2014-12-31 |
$-0.30 |
| 2014-09-30 |
$-0.30 |
| 2014-06-30 |
$-0.35 |
| 2014-03-31 |
$-0.40 |
| 2013-12-31 |
$-0.30 |
| 2013-09-30 |
$-0.35 |
| 2013-06-30 |
$-0.35 |
| 2013-03-31 |
$-0.45 |
| 2012-12-31 |
$-0.30 |
| 2012-09-30 |
$-0.20 |
| 2012-06-30 |
$-0.25 |
| 2012-03-31 |
$-0.25 |
| 2011-12-31 |
$-0.10 |
| 2011-09-30 |
$-0.25 |
| 2011-06-30 |
$1.75 |
| 2011-03-31 |
$-0.30 |
| 2010-12-31 |
$-0.30 |
| 2010-09-30 |
$-0.25 |
| 2010-06-30 |
$-0.35 |
| 2010-03-31 |
$-0.45 |
| 2009-12-31 |
$-0.45 |
| 2009-09-30 |
$-0.45 |
| 2009-06-30 |
$-0.70 |
| 2009-03-31 |
$-0.15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.001B |
$0.000B |
|
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
|
